Company

Gan & Lee Pharmaceuticals Co. Ltd

Headquarters: Beijing, China

Employees: 2,934

SSE: 603087 +0.44%

Market Cap

CN¥27.52 Billion

CNY as of Jan. 1, 2025

US$3.77 Billion

Market Cap History

Gan & Lee Pharmaceuticals Co. Ltd market capitalization over time

Evolution of Gan & Lee Pharmaceuticals Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Gan & Lee Pharmaceuticals Co. Ltd

Detailed Description

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin and its analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; and Raplin 30, an insulin aspart 30 injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date Sept. 30, 2024
Revenue TTM CN¥2.95 B
EBITDA CN¥605.3 M
Gross Profit TTM CN¥1.91 B
Profit Margin 19.71%
Operating Margin 19.55%
Quarterly Revenue Growth 37.60%
Financial Reports & Statistics

Stocks & Indices

Gan & Lee Pharmaceuticals Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603087 wb_incandescent

Details

Headquarters:

No. 8, Nanfeng West 1st Street

Huoxian Town Tongzhou District

Beijing, 101109

China

Phone: 86 10 8059 3699

Fax: 86 10 8059 3678